(Q77367182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

0 references

1 reference

1

J Reedijk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

2499-2510

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation

5 December 2019

cites work

2 references

https://opencitations.net/index/coci/api/v1/citations/10.1021/BI00324A025

21 October 2021

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Control of nephrotoxicity in the rat during repeated cis-platinum treatments

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Structural effect of intra-strand cisplatin-crosslink on palindromic DNA sequences

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

The inhibition of renal ATPase by cisplatin and some bio-transformation products

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Influence of single and multiple doses of amifostine on the efficacy and the pharmacokinetics of carboplatin in mice

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

L-Methionine increases the rate of reaction of 5′-guanosine monophosphate with the anticancer drug cisplatin: mixed-ligand adducts and reversible methionine binding

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Interaction between cisplatin and mesna in mice

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Current status of platinum-based antitumor drugs

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Pharmacokinetics of amifostine and its metabolites in patients

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Renal processing of glutathione conjugates. Role in nephrotoxicity

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Exploration of platinum-based dose-intensive chemotherapy strategies with amifostine (Ethyol).

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Monitoring the reactions of cisplatin with nucleotides and methionine by reversed-phase high-performance liquid chromatography using cationic and anionic pairing ions

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Structure and isomerization of an intrastrand cisplatin-cross-linked octamer DNA duplex by NMR analysis

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

A d(GpG)-platinated decanucleotide duplex is kinked. An extended NMR and molecular mechanics study

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

The role of the glutathione-dependent system in tumor sensitivity to cisplatin: a study of human tumor xenografts.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Platinum resistance. Experimental and clinical status.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Regeneration experiments of the platinated enzyme fumarase, using sodium diethyldithiocarbamate, thiourea, and sodium thiosulfate

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Pharmacokinetics of WR-2721.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Cisplatin and DNA repair in cancer chemotherapy

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

The interaction of DNA-targeted platinum phenanthridinium complexes with DNA

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Intermolecular displacement of S-boundL-methionine on platinum(II) by guanosine 5′-monophosphate: implications for the mechanism of action of anticancer drugs

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Newer insights into cisplatin nephrotoxicity

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

The interaction of the anti-cancer drug cisplatin with phospholipids is specific for negatively charged phospholipids and takes place at low chloride ion concentration

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Interconversion between S- and N-bound L-methionine adducts of Pt(dien)2+ (dien = diethylenetriamine) via dien ring-opened intermediates

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

Comparative adverse effect profiles of platinum drugs.

21 October 2021

1 reference

https://opencitations.net/index/coci/api/v1/references/10.1021/CR980422F

21 October 2021

Identifiers

DOI

10.1021/CR980422F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11749488%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference